Long-term outcomes of the patients with Cushing syndrome after endocrine remission
Abstract
Purpose: The study aimed to evaluate metabolic parameters and bone density measurements during the active phase and after long-term remission, as well as to present long-term follow-up results of patients with Cushing Syndrome.
Materials and Methods: In 20 patients with Cushing Syndrome, weight, waist circumference, fasting plasma glucose, lipid parameters, blood pressure and bone mineral density were evaluated during the active disease and after endocrine remission.
Results: All patients were female, premenopausal with mean age of 35±9.5 (range 27-45). During the long-term follow-up (median 60 months), weight (87.6±21.2 vs 71.1±18.8) and waist circumference (98.02±11.5,) were decreased significantly compared to baseline measurements. While total cholesterol and triglyceride values were similar between before and after remission, LDL cholesterol (143.6±35.8 vs 127.7±37.06) was decreased significantly in all patients. During the hormonal remission, 63.6% of patients’ antihypertensive medication was discontinued. Bone mineral density in lumbar spine was increased compared to the baseline values of all patients.
Conclusion: Metabolic parameters and bone status were improved during the long-term follow-up time in patients with Cushing syndrome. Age, gender and duration of hypercortisolism or following time can influence the recovery of these comorbidities.
Keywords
hypercortisolemia , type 2 diabetes mellitus , hypertension , cushing syndrome
Kaynakça
- Fleseriu M, Auchus R, Bancos I. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9:847-75.
- Wengander S, Trimpou P, Papakokkinou E. The incidence of endogenous Cushing's syndrome in the modern era. Clin Endocrinol. 2019;91:263-70.
- Hirsch D, Shimon I, Manisterski Y, Aviran-Barak N, Amitai O, Nadler V et al. Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's. Endocrine. 2018;62:712-20.
- Lodish MB, Keil MF, Stratakis CA. Cushing's syndrome in pediatrics: an update. Endocrinol Metab Clin North Am. 2018;4:451-62.
- Hakami OA, Ahmed S, Karavitaki N. Epidemiology and mortality of Cushing's syndrome. Best Pract Res Clin Endocrinol Metab. 2021;35:101521.
- Pivonello R, Faggiano A, Lombardi G, Colao A. The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metabolism Clinical North Amerixa 2005;34:327-39.
- Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxford). 2004;61:768-77
- Zacharieva S, Orbetzova M, Stoynev A. Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment. J Endocrinol Invest 2004;27:924-30.
- Sun X, Feng M, Lu L, Zhao Z, Bao X, Deng K et al.. Lipid abnormalities in patients with cushing's disease and its relationship with impaired glucose metabolism. Front Endocrinol (Lausanne). 2021;11:600323.
- Kawamata A, Iihara M, Okamoto T, Obara T. Bone mineral density before and after surgical cure of Cushing’s syndrome due to adrenocortical adenoma: prospective study. World J Surg. 2008;32:890-6.
